Henry L. Hudson

1.3k total citations
25 papers, 950 citations indexed

About

Henry L. Hudson is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Epidemiology. According to data from OpenAlex, Henry L. Hudson has authored 25 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Ophthalmology, 11 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Epidemiology. Recurrent topics in Henry L. Hudson's work include Retinal Diseases and Treatments (14 papers), Retinal Imaging and Analysis (8 papers) and Glaucoma and retinal disorders (6 papers). Henry L. Hudson is often cited by papers focused on Retinal Diseases and Treatments (14 papers), Retinal Imaging and Analysis (8 papers) and Glaucoma and retinal disorders (6 papers). Henry L. Hudson collaborates with scholars based in United States and Germany. Henry L. Hudson's co-authors include Steven E. Feldon, Peter K. Kaiser, David M. Brown, Susan Schneider, Howard Shapiro, Frank G. Holz, Nisha R. Acharya, Kang Zhang, Lawrence J. Singerman and Jason S. Slakter and has published in prestigious journals such as Ophthalmology, Journal of neurosurgery and American Journal of Ophthalmology.

In The Last Decade

Henry L. Hudson

23 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry L. Hudson United States 14 760 527 138 116 116 25 950
Steven R. Bennett United States 16 681 0.9× 449 0.9× 61 0.4× 216 1.9× 41 0.4× 24 937
Süleyman Kaynak Türkiye 17 699 0.9× 482 0.9× 98 0.7× 63 0.5× 63 0.5× 76 830
Lúcia Míriam Dumont Lucci Brazil 9 419 0.6× 352 0.7× 235 1.7× 104 0.9× 39 0.3× 26 878
ANNE M. V. BROOKS Australia 20 958 1.3× 556 1.1× 62 0.4× 123 1.1× 153 1.3× 84 1.2k
Thanos D. Papakostas United States 20 851 1.1× 612 1.2× 109 0.8× 90 0.8× 33 0.3× 67 1.0k
Guillermo de Venecia United States 13 488 0.6× 261 0.5× 112 0.8× 92 0.8× 29 0.3× 27 664
George B. Peters United States 11 907 1.2× 271 0.5× 73 0.5× 51 0.4× 69 0.6× 16 1.1k
Ryoji Yamakawa Japan 14 427 0.6× 221 0.4× 56 0.4× 148 1.3× 17 0.1× 54 679
Vinay Shah United States 16 552 0.7× 374 0.7× 87 0.6× 83 0.7× 25 0.2× 69 742
Nelson R. Sabates United States 11 444 0.6× 278 0.5× 62 0.4× 50 0.4× 84 0.7× 23 663

Countries citing papers authored by Henry L. Hudson

Since Specialization
Citations

This map shows the geographic impact of Henry L. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry L. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry L. Hudson more than expected).

Fields of papers citing papers by Henry L. Hudson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry L. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry L. Hudson. The network helps show where Henry L. Hudson may publish in the future.

Co-authorship network of co-authors of Henry L. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Henry L. Hudson. A scholar is included among the top collaborators of Henry L. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry L. Hudson. Henry L. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nguyen, Quan Dong, Peter A. Campochiaro, Syed Mahmood Shah, et al.. (2012). Evaluation of Very High- and Very Low-Dose Intravitreal Aflibercept in Patients with Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 28(6). 581–588. 19 indexed citations
3.
Nguyen, Quan Dong, Syed Mahmood Shah, David J. Browning, et al.. (2009). A Phase I Study of Intravitreal Vascular Endothelial Growth Factor Trap-Eye in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology. 116(11). 2141–2148.e1. 76 indexed citations
4.
Hudson, Henry L., R. Doyle Stulting, Jeffrey S. Heier, et al.. (2008). Implantable Telescope for End-Stage Age-related Macular Degeneration: Long-term Visual Acuity and Safety Outcomes. American Journal of Ophthalmology. 146(5). 664–673.e1. 34 indexed citations
5.
Russell, Stephen R., Henry L. Hudson, & Janice A. Jerdan. (2007). Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration—A Review of Clinical Outcomes. Survey of Ophthalmology. 52(1). S79–S90. 25 indexed citations
6.
Kaiser, Peter K., David M. Brown, Kang Zhang, et al.. (2007). Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results. American Journal of Ophthalmology. 144(6). 850–857.e4. 306 indexed citations
7.
Rosenfeld, Philip J., David S. Boyer, Neil M. Bressler, et al.. (2007). Verteporfin Therapy of Subfoveal Occult Choroidal Neovascularization in AMD Using Delayed Light Application: One-year Results of the VALIO Study. American Journal of Ophthalmology. 144(6). 970–972.e4. 6 indexed citations
8.
Browning, David J., Peter Sonkin, Henry L. Hudson, et al.. (2006). Results of a Phase I, Dose–Escalation, Safety, Tolerability, and Bioactivity Study of Intravitreous VEGF Trap in Patients With Neovascular Age–Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 47(13). 2144–2144. 1 indexed citations
9.
Hudson, Henry L., Stephen S. Lane, Jeffrey S. Heier, et al.. (2006). Implantable Miniature Telescope for the Treatment of Visual Acuity Loss Resulting from End-Stage Age-Related Macular Degeneration: 1-Year Results. Ophthalmology. 113(11). 1987–2001. 80 indexed citations
10.
Hudson, Henry L., et al.. (2005). Clinical Outcomes of Two Open–Label Pharmacokinetic Studies With Anecortave Acetate in Patients With Exudative Age–Related Macular Degeneration (AMD). 46(13). 1375–1375. 2 indexed citations
11.
Zamir, Ehud, Henry L. Hudson, Richard R. Ober, et al.. (2002). Massive mycobacterial choroiditis during highly active antiretroviral therapy. Ophthalmology. 109(11). 2144–2148. 25 indexed citations
12.
Hudson, Henry L., et al.. (1997). Retinal manifestations of acute murine typhus. International Ophthalmology. 21(3). 121–126. 14 indexed citations
13.
Hudson, Henry L., et al.. (1994). Encircling panretinal laser photocoagulation may prevent macular detachment after vitrectomy for proliferative diabetic retinopathy. International Ophthalmology. 18(2). 101–104. 4 indexed citations
14.
Hudson, Henry L., et al.. (1994). Choroidal Melanomas in Hispanic Patients. American Journal of Ophthalmology. 118(1). 57–62. 18 indexed citations
15.
Hudson, Henry L. & Steven E. Feldon. (1992). Late Overcorrection of Hypotropia in Graves Ophthalmopathy. Ophthalmology. 99(3). 356–360. 49 indexed citations
16.
Hudson, Henry L., L Levin, & Steven E. Feldon. (1991). Graves Exophthalmos Unrelated to Extraocular Muscle Enlargement. Ophthalmology. 98(10). 1495–1499. 57 indexed citations
17.
Hudson, Henry L., et al.. (1991). Pituitary tumor volume as a predictor of postoperative visual field recovery. Quantitative analysis using automated static perimetry and computed tomography morphometry.. PubMed. 11(4). 280–3. 18 indexed citations
18.
Hudson, Henry L.. (1985). How and Why Alcoholics Anonymous Works for Blacks. Alcoholism Treatment Quarterly. 2(3-4). 11–30. 4 indexed citations
19.
Hudson, Henry L., et al.. (1969). Diverticuli of the Nerve Root Sheaths. Journal of neurosurgery. 31(6). 680–682. 13 indexed citations
20.
Hudson, Henry L. & William H. McAlister. (1965). OBSTRUCTING TRACHEAL HEMANGIOMA IN INFANCY.. PubMed. 93. 428–31. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven R. Bennett Breakdown of academic impact, for papers by Süleyman Kaynak Breakdown of academic impact, for papers by Lúcia Míriam Dumont Lucci Breakdown of academic impact, for papers by ANNE M. V. BROOKS Breakdown of academic impact, for papers by Thanos D. Papakostas Breakdown of academic impact, for papers by Guillermo de Venecia Breakdown of academic impact, for papers by George B. Peters Breakdown of academic impact, for papers by Ryoji Yamakawa Breakdown of academic impact, for papers by Vinay Shah Breakdown of academic impact, for papers by Nelson R. Sabates
Rankless by CCL
2026